All posts
14550 total · page 33 of 291
Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies divests a 9.9% stake in Thyrocare, raising Rs 986 crore through NSE and BSE deals.
Surrogate Birth Sparks Legal Battle with Biological Parents
A surrogate fled to Texas to give birth after the biological parents requested a termination due to a severe heart defect diagnosis.
Medical Device Firms Challenge New Bill, Cite Misclassification with Pharma
India's medical device sector opposes a draft bill equating devices with drugs, fearing impact on innovation and investment.
Abhay Soi Critiques Proposed Price Cap on Private Hospital Rooms
Max Healthcare's Abhay Soi argues against a price cap on hospital rooms, citing investment needs.
Molbio Diagnostics Eyes ₹940 Crore Through IPO for Growth and Stake Reduction
Molbio Diagnostics plans a ₹940 crore IPO to fund expansion and reduce promoter stake, targeting high-risk investors.
Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies has sold a 9.9% stake in Thyrocare for Rs 986 crore via bulk and block deals.
Surrogate Birth Sparks Legal Battle with Biological Parents
A surrogate's decision to give birth in Texas ignites a legal battle over custody after parents requested termination.
Medical Device Industry Challenges Draft Bill Treating Devices as Drugs
India's medical device industry opposes Draft Bill 2026, citing concerns over treating devices like drugs, impacting innovation and investment.
Max Healthcare's Abhay Soi Questions Proposed Hospital Price Caps
Abhay Soi of Max Healthcare challenges proposed caps on private hospital room rents, citing investment concerns.
Molbio Diagnostics IPO: A High-Risk Bet for Long-Term Growth?
Molbio Diagnostics plans to raise ₹200 crore for expansion through an IPO, aiming to attract high-risk investors with its innovative diagnostic solutions.
Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies divests 9.9% of Thyrocare, reducing its holding to 51.02%.
Legal Battle Erupts After Surrogate Birth in Texas
A surrogate gave birth amid a legal dispute after refusing to terminate a pregnancy due to a heart defect.
Medical Device Industry Challenges Draft Bill Treating Devices as Drugs
India's medical device sector opposes draft legislation equating devices with drugs, citing potential harm to innovation and investment.
Thermo Fisher Boosts Investments in India Amid Biotech Surge
Thermo Fisher Scientific ramps up investments in India, eyeing growth in biotech and biosimilars as local drugmakers innovate.
Abhay Soi Criticizes Proposed Price Cap on Private Hospital Rooms
Max Healthcare's Abhay Soi challenges the price cap on private hospital rooms, citing investment concerns.
Molbio Diagnostics Eyes ₹940 Crore Through IPO for Expansion Plans
Molbio Diagnostics aims to raise ₹940 crore through an IPO to fund capital expenditures and reduce promoter stake.
Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies offloaded a 9.9% stake in Thyrocare Technologies for Rs 986 crore, reducing its holding to 51.02%.
Surrogate Birth Sparks Legal Battle Over Infant's Custody
A surrogate gave birth to a baby diagnosed with a heart defect, igniting a custody dispute.
Medical Device Industry Challenges India’s New Regulatory Bill
India's medical device sector opposes a draft bill treating devices like drugs, citing innovation and investment risks.
Abhay Soi Critiques Proposed Price Cap for Private Hospital Rooms
Max Healthcare's Abhay Soi questions a proposed price cap on private hospital rooms, emphasizing investment needs.
Molbio Diagnostics Aims for ₹940 Crore via IPO: A High-Risk Investment?
Molbio Diagnostics plans to raise ₹940 crore through an IPO, aiming for long-term growth. High-risk investors may find the company's global reach appealing.
Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies offloads significant Thyrocare stake, reducing its holding from 60.92% to 51.02%.
Surrogate Faces Custody Battle After Birth Amid Contractual Dispute
A surrogate gave birth in Texas after biological parents sought termination. Now, she seeks custody.
Medical Device Firms Criticize Draft Bill for Pharma-like Regulations
India's medical device sector warns that the Draft Bill's pharma-style regulations could stifle innovation and investment.
Max Healthcare's Abhay Soi Questions Price Cap on Private Hospitals
Abhay Soi argues against a blanket price cap on private hospital rooms, citing investment viability concerns.
Molbio Diagnostics Eyes ₹940 Crore Through IPO Amid Global Expansion
Molbio Diagnostics aims to raise ₹940 crore via IPO to boost manufacturing and reduce promoter stake.
Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies offloads a 9.9% stake in Thyrocare Technologies, raising Rs 986 crore through bulk and block deals.
Surrogate Birth Sparks Legal Battle Over Child Custody
A surrogate mother fled to Texas to give birth after being asked to terminate the pregnancy due to a heart defect. The child is now with biological parents amid legal disputes.
Medical Device Firms Challenge Draft Bill's Pharma-Like Regulations
India's medical device industry opposes a draft bill treating devices as pharmaceuticals, citing potential harm to innovation and investment.
Abhay Soi Criticizes Proposed Price Caps on Private Hospital Rooms
Max Healthcare's Abhay Soi warns against room rent caps, citing investment concerns.
Molbio Diagnostics Targets ₹940 Crore in IPO for Expansion and Stake Reduction
Molbio Diagnostics plans to raise ₹940 crore through its IPO, with a focus on capital expansion and reducing promoter stake.
Docon Technologies Divests 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies has sold a 9.9% stake in Thyrocare Technologies for Rs 986 crore, reducing its holding to 51.02%.
Surrogate Mother Battles for Custody After Texas Birth Amid Dispute
A surrogate mother is fighting for custody after giving birth in Texas, following a dispute with the biological parents over a severe heart defect.
Medical Device Industry Opposes Draft Bill Equating Devices with Pharmaceuticals
India's medical device sector challenges a draft bill that treats devices like drugs, warning it could stifle innovation and investment.
Abhay Soi Criticizes Proposed Cap on Private Hospital Room Rates
Max Healthcare's Abhay Soi urges reconsideration of a price cap on hospital rooms, highlighting investment needs.
Vaccine Counseling Evolves in a Shifting Post-Pandemic Era
Experts are reshaping vaccine counseling strategies to address emerging challenges in the post-pandemic world.
Understanding and Combating Vaccine Hesitancy: Insights from Harvard
Harvard experts explore the roots of vaccine hesitancy and propose strategies to enhance public trust in vaccines.
FDA Expands Enrollment for Signature Biologics' Duchenne Therapy Study
The FDA has approved expanded enrollment in Signature Biologics' trial for a new cell therapy targeting Duchenne muscular dystrophy.
FDA Advances Clinical Trials with New Modernization Initiatives
The FDA unveils strategies to accelerate clinical trials, enhancing drug development efficiency.
CRISPR Therapy Breakthrough: Success Against Drug-Resistant E. Coli
A novel CRISPR therapy has successfully treated a patient with drug-resistant E. coli, marking a potential advance in combating antibiotic resistance.
Remepy Raises $36M to Expand Hybrid Drug Development
Remepy secures $36 million in funding to enhance its hybrid drug pipeline, aiming to revolutionize treatment options.
New Automated MRI Pipeline Enhances Stroke Damage Assessment
A novel automated MRI pipeline offers a standardized approach to measuring stroke damage in preclinical studies.
Remepy Secures $36M to Boost Hybrid Drug Development Pipeline
Remepy raises $36M to advance its innovative hybrid drug pipeline, enhancing research and development efforts.
Molbio Diagnostics IPO: A High-Stakes Opportunity for Investors
Molbio Diagnostics is raising ₹200 crore for expansion and ₹740 crore via an IPO to reduce promoter stakes. The company sees growth in its TB test kits.
Docon Sells 9.9% Thyrocare Stake for Rs 986 Crore
Docon Technologies divests a 9.9% stake in Thyrocare for Rs 986 crore, reducing its holding to 51.02%.
Legal Battle Erupts After Surrogate Birth in Texas
A surrogate who gave birth in Texas is now in a legal fight with the biological parents over custody of the baby.
Medical Device Industry Opposes India's Draft Bill on Regulation
India's medical device sector challenges a draft bill treating devices like drugs, citing risks to innovation and investment.
Max Healthcare's Abhay Soi Questions Blanket Price Cap on Hospital Rooms
Abhay Soi argues against a uniform cap on hospital room charges, citing investment and expansion concerns.
Molbio Diagnostics Targets ₹940 Crore in IPO for Global Expansion
Molbio Diagnostics plans to raise ₹940 crore in its IPO, aiming to fund growth and reduce promoter stake.
Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies offloaded a 9.9% stake in Thyrocare Technologies, raising Rs 986 crore through NSE and BSE transactions.